Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why CI Stock advanced +1.16% Today — RQD Quant Desk Flash
The Cigna Group (CI) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why CI Stock advanced +1.16% Today — RQD Quant Desk Flash
The Cigna Group (CI) advanced +1.16% to $298.41 as options desks priced 60% call premium vs. 40% put protection around the $292 max-pain magnet. Solid 22% profit margin (9% return on capital), mixed timing at 13x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 77% of its 52-week range ($239.51 – $316.27) with RSI-14 at 55.6 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $8.6M in bullish call flow vs. $5.6M in put flow (Put/Call 0.66x, implied earnings swing ±7.3%).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 21.8% gross margin and $0 annual free cash flow.
Walmart (NYSE: $WMT), Eli Lilly (NYSE: $LLY), Cigna Group (NYSE: $CI), Carnival (NYSE: $CCL) and Arcos Dorados (NYS...
Walmart, Eli Lilly, Cigna, Carniva,l and Arcos Dorados objected to trading of their shares on the planned OKX-ICE tokenized stock venue, bringing the total to 38.
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Labor Department rule requires pharmacy benefit managers to disclose rebates, spread pricing and compensation.
The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common stock, payable on December 17, 2026, to shareholders of record as of the close of business on December
For questions about this article or underlying research, email help@trefis.com.
CVS Healthâs turnaround gains steam with stronger earnings, higher guidance, and dividend safety. Click for more on CVS stock.
Cigna faces margin pressure, slower buybacks, and limited upside after a downgrade to Hold. Click for more on CI stock.
https://www.wsj.com/health/healthcare/drug-middlemen-will-soon-have-to-share-details-on-how-they-are-paid-9dd31447
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live CI Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
CI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +11.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CI. Explore sector supply chains on /butterfly.
CI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CI stock moving today?
Why CI Stock advanced +1.16% Today — RQD Quant Desk Flash. Solid 22% profit margin (9% return on capital), mixed timing at 13x P/E—hold if owned, no rush to chase.